Thrivent Financial for Lutherans
AXSM icon

Thrivent Financial for Lutherans’s Axsome Therapeutics AXSM Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$265K Sell
1,565
-1
-0.1% -$173 ﹤0.01% 2416
2025
Q4 		$233K Buy
+1,566
New +$219K ﹤0.01% 2488
2020
Q4 		– Sell
-11,974
Closed -$853K – 2466
2020
Q3 		$853K Sell
11,974
-100
-0.8% -$7.79K ﹤0.01% 1662
2020
Q2 		$993K Hold
12,074
– – ﹤0.01% 1495
2020
Q1 		$710K Buy
+12,074
New +$984K ﹤0.01% 1516

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans's AXSM Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its Axsome Therapeutics (AXSM) stake by 0.06% in Q1 2026, selling an estimated $173 and leaving 1,565 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

Thrivent Financial for Lutherans first reported a position in AXSM in Q1 2020 and has held it in 5 quarters since. The position peaked at $993K in Q2 2020. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Thrivent Financial for Lutherans held 1,565 shares of Axsome Therapeutics worth $265K as of Q1 2026.
  • Thrivent Financial for Lutherans sold 1 Axsome Therapeutics share in Q1 2026, an estimated $173.
  • Axsome Therapeutics made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #2416 holding.
  • Thrivent Financial for Lutherans first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 5 quarters since.
  • Thrivent Financial for Lutherans's Axsome Therapeutics position peaked at $993K in Q2 2020.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.